A nationwide recall has been issued for a number of eye care products in the U.S. as officials urged people to stop using them "immediately." ...

ALC delivered first-quarter 2025 core earnings per share (EPS) of 73 cents, down 6.4% from the year-ago quarter’s figure. At ...

Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS ...

Alcon, Inc. ALC delivered first-quarter 2025 core earnings per share (EPS) of 73 cents, down 6.4% from the year-ago quarter’s figure. At the constant exchange rate or CER, the figure was in ...

Ocular health products declined 1% to $432 million but grew 2% in constant currency, with strong performance from the Systane family of artificial tears offset by the divestiture of certain eye drops ...

Ocular health products declined 1% to $432 million but grew 2% in constant currency, with strong performance from the Systane family of artificial tears offset by the divestiture of certain eye drops ...

Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...